Clover Health Investments Price to Book Ratio 2020-2025 | CLOV

Historical price to book ratio values for Clover Health Investments (CLOV) over the last 10 years. The current price to book ratio for Clover Health Investments as of June 20, 2025 is 4.48.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Clover Health Investments Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-06-20 3.02 4.55
2025-03-31 3.59 $0.66 5.41
2024-12-31 3.15 $0.68 4.65
2024-09-30 2.82 $0.68 4.12
2024-06-30 1.23 $0.65 1.88
2024-03-31 0.79 $0.59 1.35
2023-12-31 0.95 $0.59 1.63
2023-09-30 1.08 $0.66 1.63
2023-06-30 0.90 $0.68 1.31
2023-03-31 0.85 $0.67 1.26
2022-12-31 0.93 $0.75 1.25
2022-09-30 1.70 $0.82 2.07
2022-06-30 2.14 $0.89 2.39
2022-03-31 3.55 $1.03 3.43
2021-12-31 3.72 $1.15 3.25
2021-09-30 7.39 $0.98 7.54
2021-06-30 13.15 $0.77 17.05
2021-03-31 7.46 $1.44 5.17
2020-12-31 16.55 $-6.87 -2.41
2020-09-30 12.30 $0.21 59.59
2020-06-30 11.04 $0.21 52.95
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.511B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Hims & Hers Health (HIMS) United States $13.669B 142.02
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Claritev (CTEV) United States $0.663B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Veradigm (MDRX) United States $0.482B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00